The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Sclerotherapy with or without Octreotide for Acute Variceal Bleeding
Open accessAbstract
BACKGROUND: Sclerotherapy is considered the most effective way to stop bleeding from esophageal varices, but acute variceal bleeding is still associated with a high risk of rebleeding and death. We compared sclerotherapy alone with sclerotherapy and octreotide to control acute variceal bleeding and prevent early rebleeding in patients with cirrhosis. METHODS: In a double-blind, prospective trial, 199 patients with cirrhosis and acute variceal bleeding who underwent emergency sclerotherapy were randomly assigned to receive a continuous infusion of octreotide (25 micrograms per hour) or placebo for five days. The primary outcome measure was survival without rebleeding five days after sclerotherapy. RESULTS: After five days, the proportion of patients who had survived without rebleeding was higher in the octreotide group (85 of 98 patients, or 87 percent) than in the placebo group (72 of 101, or 71 percent; 95 percent confidence interval for the difference, 4 to 27 percent; P = 0.009). The mean number of units of blood transfused within the first 24 hours after sclerotherapy was lower in the octreotide group (1.2 units; range, 0 to 7) than in the placebo group (2.0 units; range, 0 to 10; P = 0.006). A logistic-regression analysis showed that the treatment assignment (P = 0.003) and the number of blood units transfused before any other treatment was undertaken (P = 0.002) were the only two variables independently associated with survival without rebleeding. After adjustment for base-line differences between the two groups, the odds ratio for treatment failure in the placebo group, as compared with the octreotide group, was 3.3 (95 percent confidence interval, 1.5 to 7.3). The mean (+/- SD) 15-day cumulative survival rate (estimated by the Kaplan-Meier method) was 88 +/- 12 percent in both groups. Side effects were minor, and their incidence was similar in the two groups. CONCLUSIONS: In patients with cirrhosis, the combination of sclerotherapy and octreotide is more effective than sclerotherapy alone in controlling acute variceal bleeding, but there is no difference between the overall mortality rates associated with the two approaches to treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941
The course of patients after variceal hemorrhage
Graham, D. Y., & Smith, J. L. (1981) · Gastroenterology · doi:10.1016/0016-5085(81)90144-x · Cited by 996
Definitions, methodology and therapeutic strategies in portal hypertension
de Franchis, R., Pascal, J. P., Ancona, E., Burroughs, A. K., Henderson, M., Fleig, W., Groszmann, R., Bosch, J., Sauerbruch, T., Soederlund, C., et al. (1992) · Journal of Hepatology · doi:10.1016/0168-8278(92)90044-p · Cited by 291
Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding
Burroughs, A. K., McCormick, P. A., Hughes, M. D., Sprengers, D., D'heygere, F., & McIntyre, N. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91166-4 · Cited by 253
Octreotide infusion or emergency sclerotherapy for variceal haemorrhage
Sung, J. J. Y., Lai, C.-W., Chan, F. K. L., Leung, J. W. C., Kassianides, C., Chung, S. C. S., Yung, M.-Y., & Li, A. K. C. (1993) · The Lancet · doi:10.1016/0140-6736(93)91758-e · Cited by 194
Tamponade and injection sclerotherapy in the management of bleeding oesophageal varices
Barsoum, M. S., Bolous, F. I., El-Rooby, A. A., Rizk-Allah, M. A., & Ibrahim, A. S. (1982) · Journal of British Surgery · doi:10.1002/bjs.1800690206 · Cited by 177
Burroughs, A. K., Hamilton, G., Phillips, A. N., Mezzanotte, G., McIntyre, N., & Hobbs, K. E. F. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909283211303 · Cited by 154
Hwang, S., Lin, H., Chang, C., Lee, F., Lu, C.-W., Hsia, H.-C., Wang, S.-S., Lee, S., Tsai, Y., & Lo, K. (1992) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80663-4 · Cited by 114
Silvain, C., Carpentier, S., Sautereau, D., Czernichow, B., Métreau, J., Fort, E., Ingrand, P., Boyer, J., Pillegand, B., Doffël, M., et al. (1993) · Hepatology · doi:10.1002/hep.1840180111 · Cited by 100
Self-citationOptimized analysis of recurrent bleeding and death in patients with cirrhosis and esophageal varices
Thomsen, B. S., Møller, S., & Sørensen, T. I. A. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80315-0 · Cited by 30
Cited by
Improved survival after variceal bleeding in patients with cirrhosis over the past two decades
Carbonell, N., Pauwels, A., Serfaty, L., Fourdan, O., Lévy, V. G., & Poupon, R. (2004) · Hepatology · doi:10.1002/hep.20339 · Cited by 842
Reversal of Type 1 Hepatorenal Syndrome With the Administration of Midodrine and Octreotide
Angeli, P., Volpin, R., Gerunda, G., Craighero, R., Roner, P., Merenda, R., Amodio, P., Sticca, A., Caregaro, L., Maffei-Faccioli, A., et al. (1999) · Hepatology · doi:10.1002/hep.510290629 · Cited by 564
Garcia–Tsao, G. (2001) · Gastroenterology · doi:10.1053/gast.2001.22580 · Cited by 471
Gastroesophageal Variceal Hemorrhage
Sharara, A. I., & Rockey, D. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmra003007 · Cited by 425
Portal hypertension and variceal bleeding: An AASLD single topic symposium†
Grace, N. D., Groszmann, R. J., Garcia-Tsao, G., Burroughs, A. K., Pagliaro, L., Makuch, R. W., Bosch, J., Stiegmann, G. V., Henderson, M. J., de Franchis, R., et al. (1998) · Hepatology · doi:10.1002/hep.510280339 · Cited by 398
Metadata
- Authors
- Besson, I., Ingrand, P., Person, B., Boutroux, D., Heresbach, D., Bernard, P., Hochain, P., Larricq, J., Gourlaouen, A., Ribard, D., Kara, N. M., Legoux, J.-L., Pillegand, B., Becker, M.-C., Di Costanzo, J., Metreau, J.-M., Silvain, C., & Beauchant, M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1995-08-31
- Volume
- 333
- Issue
- 9
- Pages
- 555-560
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2339736887
- Cited by
- 274
- References
- 10
- FWCI
- 14.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sclerotherapy with or without Octreotide for Acute Variceal Bleeding. https://app.cochat.ai/papers/10.1056/nejm199508313330904
- The paper
- Besson, I., Ingrand, P., Person, B., Boutroux, D., Heresbach, D., Bernard, P., Hochain, P., Larricq, J., Gourlaouen, A., Ribard, D., Kara, N. M., Legoux, J.-L., Pillegand, B., Becker, M.-C., Di Costanzo, J., Metreau, J.-M., Silvain, C., & Beauchant, M. (1995). Sclerotherapy with or without Octreotide for Acute Variceal Bleeding. New England Journal of Medicine. https://doi.org/10.1056/nejm199508313330904
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.